Shopping Cart
- Remove All
- Your shopping cart is currently empty
CL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering the MyD88-dependent signaling pathway and activating NF-κB and IRF7 to elicit the production of inflammatory cytokines and type I interferon (IFN).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $34 | In Stock | |
1 mL x 10 mM (in DMSO) | $85 | In Stock |
Description | CL075 (3M002) is a selective TLR8 agonist with immunomodulatory activity, triggering the MyD88-dependent signaling pathway and activating NF-κB and IRF7 to elicit the production of inflammatory cytokines and type I interferon (IFN). |
In vitro | CL075 (2 μM) induces the production of IL-6, IL-8, and IFN-γ in rabbit splenocytes within 4 hours, stimulates total IgM production and cell proliferation in rabbit splenocytes within 48 hours, and activates rabTLR8 in 293 cells within 7 hours.[1] |
In vivo | CL075 (5 μM; s.c.) activates mild antigen-specific antibody responses in rabbits.[1] |
Alias | CL-075, 3M002 |
Molecular Weight | 243.33 |
Formula | C13H13N3S |
Cas No. | 256922-53-9 |
Smiles | CCCc1nc2c(N)nc3ccccc3c2s1 |
Relative Density. | 1.313 g/cm3 (Predicted) |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 19.8 mg/mL (81.4 mM ), Sonication and heating are recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.